BlueWillow Biologics
About:
BlueWillow is a biopharmaceutical company that focuses on developing and commercializing topical antiseptic and anti-infective products.
Website: http://www.bluewillow.com
Twitter/X: nanobio
Top Investors: National Institute of Allergy and Infectious Diseases, Bill & Melinda Gates Foundation, Small Business Innovation Research, Venture Investors, Wolverine Venture Fund
Description:
BlueWillow Biologics operates as a clinical-stage, privately-held biopharmaceutical company. It focuses on developing and commercializing topical antiseptic and anti-infective products and intranasal vaccines using its patented nanotechnology platform. Its platform employs novel oil-in-water nano-droplets for products administered to the skin and nose. The company was founded as a spin-off from the University of Michigan and is headquartered in Ann Arbor, Michigan.
$86.3M
$1M to $10M
Ann Arbor, Michigan, United States
2000-01-01
john.coffey(AT)nanobio.com
James R Baker
11-50
2018-09-26
Private
© 2025 bioDAO.ai